Apyx Medical Q4 GAAP EPS $(0.28) May Not Be Comparable To $(0.18) Estimate, Sales $14.66M Miss $14.85M Estimate
Apyx Medical Q4 GAAP EPS $(0.28) May Not Be Comparable To $(0.18) Estimate, Sales $14.66M Miss $14.85M Estimate
Apyx Medical第四季度GAAP每股收益美元（0.28美元）可能无法与预期的美元（0.18美元）相提并论，销售额为1466万美元未达到1485万美元的预期
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.18) by 55.56 percent. This is a 64.71 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $14.66 million which missed the analyst consensus estimate of $14.85 million by 1.27 percent. This is a 16.26 percent increase over sales of $12.61 million the same period last year.
Apyx Medical（纳斯达克股票代码：APYX）公布的季度亏损为每股0.28美元，比分析师普遍预期的0.18美元（0.18美元）低55.56％。这比去年同期每股亏损0.17美元（0.17美元）下降了64.71％。该公司公布的季度销售额为1466万美元，比分析师普遍预期的1485万美元低1.27％。这比去年同期的1,261万美元的销售额增长了16.26％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。